Statin Use and Chemoradiation in Esophageal Squamous Cell Carcinomas: Ready for Prime Time?

J Thorac Oncol. 2023 Aug;18(8):970-971. doi: 10.1016/j.jtho.2023.05.020.

Author

Affiliation

¹ Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: SHLin@mdanderson.org.

PMID: 37479326
DOI: 10.1016/j.jtho.2023.05.020

No abstract available

Publication types

Editorial
Comment

MeSH terms

Chemoradiotherapy
Esophageal Neoplasms* / drug therapy
Esophageal Squamous Cell Carcinoma* / therapy
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Lung Neoplasms*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors